Monthly Archives: October, 2018
Congresswoman Eleanor Holmes Norton Co-Sponsors HR 1187 for Functional GI Research
According to IFFGD and the official Congressional legislative database Congress.gov, Congresswoman Eleanor Holmes Norton (D-DC-at large) is the latest member of the House of Representatives to sign on in October 2018 as a co-sponsor of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. Congresswoman Norton is serving her fourteenth term representing, Washington, …
U.S. Food and Drug Administration Seeks Public Comment on Prucalopride for Chronic Idiopathic Constipation (CIC) and Tegaserod for Irritable Bowel Syndrome with Constipation (IBS-C) by October 16, 2018
UPDATE: 10/19/2018: The Gastrointestinal Drugs Advisory Committee voted to recommend approval of both of the medications under consideration below. This does not mean that the medications have the full approval of the FDA and can be made available yet. However, it is a positive step forward in the process toward full approval. On Wednesday, …
IBS IMPACT 